Indications
1.Light Therapy Increases Protective Proteins in the Brain and Reduces Harmful Proteins Linked to Alzheimer's Disease
2.Cognitive function, sleep, and behavioral symptoms in Alzheimer's disease and behavioral symptoms improved
Technical Parameters
|
Number of diodes: |
320 LEDs [ODM is acceptable] |
|
Wavelength: |
810nm LED [ODM is acceptable] |
|
Frequency: |
1-20,000 Hz can be adjusted |
|
The default frequency setting: |
30Hz--The frequency data is not displayed, but there are buttons available to adjust it. |
|
Duration: |
0-30 minutes adjustable |
|
The intensity of the LED: |
25, 50, 75, or 100% can be adjusted, which means 4 levels can be adjusted |
|
Remote controller: |
wireless remote controller |
|
Total Max. output power : |
16W |
|
Single LED max. output power: |
50mW |
|
Operation: |
It can be controlled manually or by a remote controller |
Advantages
1.Experience the revitalizing energy of near-infrared light to stimulate cellular energy production and promote brain health.
2.COZING helmet is ergonomically designed with adjustable wearing style to make you feel comfortable during each revitalization process.
3.COZING helmet is a brain-boosting device, helping you to enhance your intelligence and reach the best state.
4.Adjustable frequency: 1-20,000 Hz.
5. Wavelength, number of LEDs and style can be customized.
COZING-C320red light alzheimer's Clinical study:
1.Background: Alzheimer's disease (AD) is the most common neurodegenerative disease in the Western world and a common cause of dementia. This study investigated the expression profile of heat shock proteins (HSP) involved in maintaining neuronal health in the AD mouse model and whether long-term treatment with 810 infrared light (COZING-C320) altered the expression profile of HSP and amyloidosis in female mice.
2.METHODS/PRINCIPAL FINDINGS: Quantitative immunoblotting and immunohistochemistry were used to examine the expression of proteins such as heat shock proteins (HSP), phosphorylated tau proteins (tau-P), amyloid precursor proteins (APP), β-amyloid 1-40 (Aβ) and Aβ1-42. The study population consisted of 3-, 7-, and 12-month-old mice, as well as female mice that received 5 months of chronic treatment with COZING-C320. In mice at 12 months of age (a critical period for AD progression), HSP40 and HSP105 levels were reduced. αB-crystallin, Aβ1-42, and tau-P levels were elevated during this period, especially between 3 and 7 months of age. Long-term treatment of female mice with COZING-C320 resulted in significantly higher levels of HSP60, 70, and 105 as well as phosphorylated HSP27 (P-HSP27) (50-139%), while the levels of αB-crystallin, APP, tau-P, Aβ1-40, and Aβ1-42 proteins were significantly decreased at 7 months of age (43-81%). In addition, COZING-C320 treatment significantly reduced the number of Aβ1-42 plaques in the cerebral cortex, albeit modestly.
3.CONCLUSIONS/SIGNIFICANT FINDINGS: COZING-C320 therapy provides a novel non-invasive and safe approach to upregulate a range of stress-responsive proteins in the brain that are known to reduce protein aggregation and neuronal apoptosis. This approach has recently entered Alzheimer's disease (AD) clinical trials in the United States and may provide a new disease-modifying therapy for a range of neurological conditions.
Why Choose Our Alzheimer's Light Therapy Helmet?
✔ Backed by Science – Clinically proven 810nm wavelength
✔ Highest LED Count (320) – Full brain coverage
✔ Adjustable Frequencies – Customizable therapy
✔ Safe & Effective – No side effects, long-term benefits
Order Now & Support Brain Health Naturally!
��Free Shipping | 1-Year Warranty | 24/7 Customer Support
Hot Tags: light therapy helmet for alzheimer, China light therapy helmet for alzheimer manufacturers, suppliers, factory, photo bio modulation therapy, laser photobiomodulation therapy, photobiomodulation brain, brain light therapy device, red light therapy device for brain, light therapy for brain
